PURPOSE OF REVIEW: Genetic LCAT deficiency is a rare metabolic disorder characterized by low-plasma HDL cholesterol levels. Clinical manifestations of the disease include corneal opacification, anemia, and renal disease, which represents the major cause of morbidity and mortality in carriers. RECENT FINDINGS: Biochemical and clinical manifestations of the disease are very heterogeneous among carriers. The collection of large series of affected individuals is needed to answer various open questions on this rare disorder of lipid metabolism, such as the cause of renal damage in patients with complete LCAT deficiency and the cardiovascular risk in carriers of different LCAT gene mutations. SUMMARY: Familial LCAT deficiency is a rare disease, with serious clinical manifestations, which can occur in the first decades of life, and presently with no cure. The timely diagnosis in carriers, together with the identification of disease biomarkers able to predict the evolution of clinical manifestations, would be of great help in the identification of carriers to address to future available therapies.
Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020 / C. Pavanello, L. Calabresi. - In: CURRENT OPINION IN LIPIDOLOGY. - ISSN 0957-9672. - 31:4(2020 Aug), pp. 232-237.
|Titolo:||Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020|
PAVANELLO, CHIARA (Primo)
CALABRESI, LAURA (Ultimo) (Corresponding)
|Parole Chiave:||HDL; lecithin--cholesterol acyltransferase; lecithin--cholesterol acyltransferase deficiency;|
|Settore Scientifico Disciplinare:||Settore BIO/14 - Farmacologia|
|Data di pubblicazione:||ago-2020|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1097/MOL.0000000000000697|
|Appare nelle tipologie:||01 - Articolo su periodico|
File in questo prodotto:
|Genetic,_biochemical,_and_clinical_features_of.9.pdf||Publisher's version/PDF||Administrator Richiedi una copia|